Literature DB >> 10958937

Comparative genomic hybridization in inherited and sporadic ovarian tumors in Israel.

Y Patael-Karasik1, M Daniely, W H Gotlieb, G Ben-Baruch, J Schiby, G Barakai, B Goldman, A Aviram, E Friedman.   

Abstract

To gain an understanding of the molecular mechanisms of ovarian cancer, we analyzed 16 ovarian tumors from Jewish Israeli patients by comparative genomic hybridization: 12 invasive epithelial tumors (including three BRCA1 and one BRCA2 mutation carriers), 2 primary peritoneal carcinomatosis, 1 pseudomyxoma peritoneii tumor, and 1 sertoli cell tumor. We similarly analyzed 1 normal ovary from a BRCA1 mutation carrier, and 3 metastases. The most common abnormalities in epithelial tumors were amplification of 8q22.1-ter (8/12, 66.6%), 1q22-32.1 (5/12, 41.6%), 3q, 10p (4/12, 33.3% for each), and deletions of 9q (5/12, 41.6%) and 16q21-24 (4/12, 33.3%). All 3 BRCA1 mutation carriers and 2 of 8 sporadic cases displayed 9q deletion, and 2 of 3 BRCA1 mutation carriers, but none of the sporadic cases, had deletion of chromosome 19. The range of genetic changes in primary peritoneal tumors and epithelial ovarian cancers was similar, though the mean number of alterations in the former was less (3.5/tumor versus 8/tumor). Our preliminary results may indicate that inherited predisposition to ovarian cancer possibly entails preferential somatic deletions of chromosomes 9 and 19.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10958937     DOI: 10.1016/s0165-4608(00)00224-7

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  12 in total

1.  Suppression of survival signalling pathways by the phosphatase PHLPP.

Authors:  Audrey K O'Neill; Matthew J Niederst; Alexandra C Newton
Journal:  FEBS J       Date:  2012-03-16       Impact factor: 5.542

2.  Depletion of Pleckstrin homology domain leucine-rich repeat protein phosphatases 1 and 2 by Bcr-Abl promotes chronic myelogenous leukemia cell proliferation through continuous phosphorylation of Akt isoforms.

Authors:  Isao Hirano; Satoki Nakamura; Daisuke Yokota; Takaaki Ono; Kazuyuki Shigeno; Shinya Fujisawa; Kaori Shinjo; Kazunori Ohnishi
Journal:  J Biol Chem       Date:  2009-03-04       Impact factor: 5.157

Review 3.  Turning off AKT: PHLPP as a drug target.

Authors:  Alexandra C Newton; Lloyd C Trotman
Journal:  Annu Rev Pharmacol Toxicol       Date:  2014       Impact factor: 13.820

4.  Systems biology in cancer research: genomics to cellomics.

Authors:  Jackie L Stilwell; Yinghui Guan; Richard M Neve; Joe W Gray
Journal:  Methods Mol Biol       Date:  2007

5.  Molecular-cytogenetic characterisation of sex cord-stromal tumours: CGH analysis in sertoli cell tumours of the testis.

Authors:  I Verdorfer; A Höllrigl; U Strasser; M Susani; A Hartmann; H Rogatsch; G Mikuz
Journal:  Virchows Arch       Date:  2007-02-28       Impact factor: 4.064

Review 6.  Targeting abnormal DNA double strand break repair in cancer.

Authors:  Feyruz V Rassool; Alan E Tomkinson
Journal:  Cell Mol Life Sci       Date:  2010-08-10       Impact factor: 9.261

Review 7.  PHLiPPing the switch on Akt and protein kinase C signaling.

Authors:  John Brognard; Alexandra C Newton
Journal:  Trends Endocrinol Metab       Date:  2008-05-27       Impact factor: 12.015

8.  WWOX protein expression varies among ovarian carcinoma histotypes and correlates with less favorable outcome.

Authors:  María I Nunez; Daniel G Rosen; John H Ludes-Meyers; Martín C Abba; Hyunsuk Kil; Robert Page; Andres J P Klein-Szanto; Andrew K Godwin; Jinsong Liu; Gordon B Mills; C Marcelo Aldaz
Journal:  BMC Cancer       Date:  2005-06-27       Impact factor: 4.430

9.  DNA copy number profiling reveals extensive genomic loss in hereditary BRCA1 and BRCA2 ovarian carcinomas.

Authors:  M M Kamieniak; I Muñoz-Repeto; D Rico; A Osorio; M Urioste; J García-Donas; S Hernando; L Robles-Díaz; T Ramón Y Cajal; A Cazorla; R Sáez; J M García-Bueno; S Domingo; S Borrego; J Palacios; M A van de Wiel; B Ylstra; J Benítez; M J García
Journal:  Br J Cancer       Date:  2013-04-04       Impact factor: 7.640

10.  WD repeat protein WDR48 in complex with deubiquitinase USP12 suppresses Akt-dependent cell survival signaling by stabilizing PH domain leucine-rich repeat protein phosphatase 1 (PHLPP1).

Authors:  Narmadha Reddy Gangula; Subbareddy Maddika
Journal:  J Biol Chem       Date:  2013-10-21       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.